Liz Cross: Addressing antimicrobial resistance

Addressing antimicrobial resistance

Liz Cross, advanced nurse practitioner and non-medical prescriber, is taking huge steps in reducing the unnecessary prescribing of antibiotics to address antimicrobial resistance (AMR). What is your...

Lack of public awareness in choice of hospitals when accessing NHS treatment

A new poll by Populus has identified a lack of public awareness in choice of hospitals when accessing NHS treatment. Populus interviewed 6116 adults online...
link between Type 2 diabetes and cardiovascular disease risk

New research into the link between Type 2 diabetes and cardiovascular disease risk

New research into the link between Type 2 diabetes and cardiovascular disease risk highlights improvements in cardiovascular risk for women developing Type 2 diabetes...

The role of clinical pharmacists in primary and community care

The General Practitioners Committee of the British Medical Association’s longstanding ambition for every GP practice to benefit from having a pharmacist is now much...
Digital experts to join cancer and mental health teams

NHSX: digital experts to join cancer and mental health teams

Digital experts to join cancer and mental health teams as part of the growth of NHSX - a new joint organisation for digital, data...
link between Type 2 diabetes and cardiovascular disease risk

Virtual reality for doctors – preparing for diabetes emergencies

Virtual reality for doctors - How virtual reality can prepare doctors for diabetes emergencies The NHS England diabetes team has partnered with Oxford Medical Simulation...
The cost of prescriptions report from NHS Digital

The cost of prescriptions report published

The cost of prescriptions dispensed in the community and the number of items dispensed during the 2018 calendar year has been published by NHS...
Type 2 diabetes screening in community pharmacies

Type 2 diabetes screening in community pharmacies

Type 2 diabetes screening in community pharmacies could increase early diagnosis and reduce NHS costs, according to a new study. The study by Boots UK...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Dotmatics wins Queen's Award for Enterprise: International Trade

2019 HSJ Partnership Awards winners

The 2019 HSJ Partnership Awards winners have been announced and they showcased effective partnership working within the NHS. With more than 700 NHS partners and...

Latest articles

Oral health has been isolated from traditional healthcare and health policy for too long fuelling an oral health crisis according to a Lancet Series.

Big Sugar and neglect by global health community fuel oral health crisis 

Oral health has been isolated from traditional healthcare and health policy for too long, despite the major global public health burden of oral diseases,...
New statistics show decrease in animals used for R&D

New statistics show decrease in animals used for R&D

The Home Office has released its annual statistics on animals used in research in Great Britain. It shows 3.52 million procedures were carried out...
New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford.

New insight into microRNA function can give gene therapy a boost

New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford. They have shown that...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis.

Gene silencing therapy for hereditary amyloidosis approved by NICE

NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis. RNA interference (RNAi) therapeutics company, Alnylam UK Limited has welcomed a decision from the...
AstraZeneca to appeal NICE's osimertinib decision

AstraZeneca to appeal NICE’s osimertinib decision

AstraZeneca to appeal NICE's osimertinib decision following it not being recommended for use within NHS England. AstraZeneca will appeal a decision by the National Institute...

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...

How to write a standout CV

The job market is getting more competitive by the day, as highly-qualified candidates fiercely compete for the top jobs. A carefully constructed CV is...